Merck, a major U.S. pharmaceutical company, announced this week that its drug “Tredaptive” has failed a clinical trial. The trial was meant to test the drug for its ability to improve patients’ heart health by increasing their levels of “good”…
Diabetes Treatment Drug Shows Encouraging Results in Trials
At the 48th annual meeting of the European Association for the Study of Diabetes (EASD) this week in Berlin, Boehringer Ingelheim Pharmaceuticals, and Eli Lilly announced data from three analyses for linagliptin, a new type 2 diabetes treatment. The studies…
Lung Cancer Drug Trial Cancelled
This week, ArQule, a biotechnology company focused on developing “next-generation” small-molecule cancer drugs, announced that a drug trial for a lung cancer treatment it developed has been stopped early. The independent Data Monitoring Committee (DMC) overseeing the Phase 3 trial…
Cancer Drug Erbitux Fails to Produce Results in Trials
The cancer drug Erbitux, which is manufactured by Merck & Co., Inc, has failed to produce any significant new results for the second month in a row. The German pharmaceutical company, one of the largest in the world, watched helplessly…